Cargando…
Aerosol delivery systems for treating obstructive airway diseases during the SARS-CoV-2 pandemic
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes CoronaVirus Disease 2019 (COVID-19), has resulted in a worldwide pandemic and currently represents a major public health crisis. It has caused outbreaks of illness through person-to-person transmission of the virus mainly...
Autores principales: | Lavorini, Federico, Usmani, Omar S., Dhand, Rajiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323748/ https://www.ncbi.nlm.nih.gov/pubmed/34331192 http://dx.doi.org/10.1007/s11739-021-02812-x |
Ejemplares similares
-
SARS-CoV-2 and myocardial injury: a role for Nox2?
por: Violi, Francesco, et al.
Publicado: (2020) -
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
por: Testa, Sophie, et al.
Publicado: (2020) -
Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines
por: Marcucci, Rossella, et al.
Publicado: (2021) -
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies
por: Albini, Adriana, et al.
Publicado: (2020) -
Thrombosis centres and AVKs monitoring in COVID-19 pandemic
por: Barcellona, Doris, et al.
Publicado: (2020)